Follow your doctor’s advice about having your skin checked for skin cancer while taking Olumiant. People taking a medicine in the class of medicines called JAK inhibitors have a higher risk of certain cancers, including lymphoma and lung cancer, especially if you are a current or past smoker. Olumiant may increase your risk of lymphoma and other cancers, including skin cancers. Increased risk of death in people 50 years of age or older who have at least 1 heart disease risk factor and are taking a medicine in a class of medicines called JAK inhibitors.If you get a serious infection, your doctor may stop Olumiant until your infection is controlled. burning with urination or urinating more often than normal.warm, red, or painful skin or sores on your body.Your doctor is your source for medical advice. †Your Companion in Care provided is not a medical professional. Subject to additional terms and conditions, which can be found at /olumiant-together. Offer void where prohibited by law and subject to change or discontinue without notice. This offer is invalid for Patients without commercial drug insurance or whose prescription claims for Olumiant are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE ®/CHAMPUS, or any State Patient or Pharmaceutical Assistance Program. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. Participation in the program requires a valid patient HIPAA authorization. Monthly and annual caps are set at Lilly’s absolute discretion and may be changed by Lilly with or without notice. Offer subject to a monthly cap and a separate annual cap. A new PA and appeal or medical exception (ME) must be submitted every 12 months or as required by Lilly to verify coverage status and potential eligibility for the $5 program. If coverage is denied, an appeal must be submitted prior to 5 th month fill. Participation in the $25 program requires submission of a prior authorization (PA). Patients must have commercial drug insurance and prescription consistent with FDA-approved product labeling to pay as little as $25 for a 30-day supply of Olumiant.
XOLAIR CO PAY CARD PLUS
Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate annual cap of $9,100. Patients must have coverage for Olumiant through their commercial drug insurance and a prescription consistent with FDA approved product labeling to pay as little as $5 for a 30-day supply of Olumiant. * Offer good until or for up to 36 months from Patient qualification into the program, whichever comes first. A Companion in Care ™ will be able to answer your questions. It does not store any personal data.To find out, call Olumiant Together at 1-844-OLUMIANT (1-84). The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. The cookie is used to store the user consent for the cookies in the category "Performance". This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. The cookies is used to store the user consent for the cookies in the category "Necessary". The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
The cookie is used to store the user consent for the cookies in the category "Analytics". These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly.
0 kommentar(er)
